Testing effectiveness (Phase 2)Study completedNCT05549219
What this trial is testing
24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG
Who this might be right for
Pmm2-CDGPhosphomannomutase 2 Deficiency
Glycomine, Inc. 27